HCV-replication after liver transplantation: Influence of immunosuppressive therapy.

被引：0
|
作者：
Tisone, G
Angelico, M
Gandin, C
Romagnoli, J
Palmieri, G
Montano, M
Orlando, G
Negrini, S
Pisani, F
Casciani, CU
机构：
[1] UNIV ROMA TOR VERGATA,DEPT SURG,LIVER TRANSPLANT CTR,ROME,ITALY
[2] UNIV ROMA TOR VERGATA,DEPT PATHOL,ROME,ITALY
[3] UNIV ROMA TOR VERGATA,DEPT GASTROENTEROL,ROME,ITALY
来源：
HEPATOLOGY | 1996年 / 24卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1850 / 1850
页数：1
相关论文
共 50 条
  • [1] The influence of mTor-Inhibitors on HCV replication after liver transplantation
    Ecker, Eva-Maria
    Frey, Alexandra
    Piras-Straub, Katja
    Walker, Andreas
    Gerken, Guido
    Herzer, Kerstin
    HEPATOLOGY, 2014, 60 : 533A - 533A
  • [2] Dynamics of HCV replication after liver transplantation: Influence of immunosuppression with or without steroids.
    Angelico, M
    Tisone, G
    Baiocchi, L
    Montano, M
    Palmieri, GP
    Orlando, G
    Negrini, S
    Gandin, C
    Pisani, F
    Casciani, CU
    HEPATOLOGY, 1997, 26 (04) : 1381 - 1381
  • [3] Influence of immunosuppressive therapy in the incidence of chronic renal failure after liver transplantation
    Planas, JMM
    Herreros, A
    Rubio, E
    Lopez, J
    Gomez, A
    Sanchez-Turrion, V
    Revilla, J
    Navarrete, E
    Gonzalez, Y
    Cuervas-Mons, V
    JOURNAL OF HEPATOLOGY, 2003, 38 : 45 - 45
  • [4] Influence of immunosuppressive therapy in the incidence of chronic renal dysfunction after liver transplantation
    Planas, JMM
    Cuervas-Mons, V
    Rubio, E
    de Tejada, AH
    Sanchez-Turrion, V
    Gomez, A
    Lopez-Monclus, J
    LIVER TRANSPLANTATION, 2003, 9 (06) : C5 - C5
  • [5] Immunosuppressive regimens influence recurrence and progression of Hepatitis C (HCV) after orthotopic liver transplantation (OLT).
    Hunt, J
    Gordon, F
    Lewis, WD
    Pomfret, E
    Pomposelli, J
    Jenkins, R
    Khettry, U
    LABORATORY INVESTIGATION, 2001, 81 (01) : 197A - 197A
  • [6] Immunosuppressive regimens influence recurrence and progression of Hepatitis C (HCV) after orthotopic liver transplantation (OLT).
    Hunt, J
    Gordon, F
    Lewis, WD
    Pomfret, E
    Pomposelli, J
    Jenkins, R
    Khettry, U
    MODERN PATHOLOGY, 2001, 14 (01) : 197A - 197A
  • [7] TOLERANCE AND MINIMIZATION OF IMMUNOSUPPRESSIVE THERAPY AFTER LIVER TRANSPLANTATION
    Gerasimova, O. A.
    Borovik, V. V.
    Marchenko, N., V
    Tileubergenov, I. I.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2021, 23 (03): : 162 - 170
  • [8] Lymphocele after renal transplantation: The influence of the immunosuppressive therapy
    Tondolo, V.
    Citterio, F.
    Massa, A.
    Salerno, M. P.
    Rornagnoli, J.
    Nanni, G.
    Castagneto, M.
    TRANSPLANTATION PROCEEDINGS, 2006, 38 (04) : 1051 - 1052
  • [9] Immunosuppressive therapy in liver transplantation
    Conti, F
    Morelon, E
    Calmus, Y
    JOURNAL OF HEPATOLOGY, 2003, 39 (05) : 664 - 678
  • [10] Effect of immunosuppressive regimens on the occurrence of severe HCV hepatitis after liver transplantation.
    Alsatie, M
    Lumeng, L
    Chalasani, N
    Yedidag, A
    Pescovitz, M
    Filo, R
    Qi, RA
    Rouch, D
    Kwo, PY
    HEPATOLOGY, 2002, 36 (04) : 657A - 657A
12345